At the industry's top events, pharma professionals can dive into these issues and more through educational sessions, networking events and keynote presentations from industry leaders. Here's a look at ...

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ research progress. Here’s a list of conferences to watch for in 2027.

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents.

Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026" has been added to ResearchAndMarkets.com's offering. The Manufacturing and ...

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026" has been added to ...

The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind ...

In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive ...

How significant is FDA approval of Journavx for Vertex? Vertex CEO Reshma Kewalramani described the FDA approval of Journavx as "a historic milestone for the 80 million people in America who are ...

Vertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area. The company is slowly developing and launching medicines in other markets. These 10 stocks could mint the next ...